Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,453.00
+56.00 (1.04%)
Sep 26, 2025, 3:30 PM JST
1.04%
Market Cap405.37B
Revenue (ttm)161.48B
Net Income (ttm)11.80B
Shares Out74.34M
EPS (ttm)158.71
PE Ratio34.36
Forward PE32.15
Dividend104.00 (1.91%)
Ex-Dividend DateDec 29, 2025
Volume196,400
Average Volume198,470
Open5,390.00
Previous Close5,397.00
Day's Range5,390.00 - 5,460.00
52-Week Range4,850.00 - 6,350.00
Beta0.48
RSI50.75
Earnings DateNov 11, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin... [Read more]

Founded 1886
Employees 3,615
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial Statements

News

There is no news available yet.